These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10853626)

  • 41. Evolution of angiotensin-converting enzyme inhibition in hypertension, heart failure, and vascular protection.
    Parmley WW
    Am J Med; 1998 Jul; 105(1A):27S-31S. PubMed ID: 9707265
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Angiotensin converting enzyme inhibitors and the cardiovascular system.
    Dzau VJ
    J Hypertens Suppl; 1992 Jun; 10(3):S3-10. PubMed ID: 1386105
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The antagonistic effect of aspirin on the expression of prostaglandin participation in the antihypertensive activity of ACE inhibitors].
    Alimento M; Campodonico J; Santambrogio G; Rossi M; Trabattoni D; Celeste F; Guazzi M
    Cardiologia; 1997 Jun; 42(6):605-10. PubMed ID: 9289376
    [TBL] [Abstract][Full Text] [Related]  

  • 44. American College of Cardiology/American Heart Association Chronic Heart Failure Evaluation and Management guidelines: relevance to the geriatric practice.
    Ahmed A
    J Am Geriatr Soc; 2003 Jan; 51(1):123-6. PubMed ID: 12534856
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Angiotensin converting enzyme (ACE) inhibitors and heart failure. The consequences of underprescribing.
    Andersson F; Cline C; Rydén-Bergsten T; Erhardt L
    Pharmacoeconomics; 1999 Jun; 15(6):535-50. PubMed ID: 10538327
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Interaction of angiotensin-converting enzyme inhibitors with aspirin].
    Agustí A; Diògene E
    Med Clin (Barc); 2003 Nov; 121(16):631-3. PubMed ID: 14636540
    [No Abstract]   [Full Text] [Related]  

  • 47. Using aspirin and ACE inhibitors in combination: why the hullabaloo?
    Peterson JG; Lauer MS
    Cleve Clin J Med; 2001 Jun; 68(6):569-74. PubMed ID: 11405620
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aspirin and ACE-inhibitors: for wedding or funeral?
    Barbash IM; Gottlieb S; Goldbourt U; Behar S; Leor J
    J Thromb Thrombolysis; 2001 Apr; 11(2):163-9. PubMed ID: 11406732
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of aspirin and clopidogrel on plasma brain natriuretic peptide in patients with heart failure receiving ACE inhibitors.
    Meune C; Wahbi K; Fulla Y; Cohen-Solal A; Duboc D; Mahé I; Simoneau G; Bergmann JF; Weber S; Mouly S
    Eur J Heart Fail; 2007 Feb; 9(2):197-201. PubMed ID: 16914369
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New competition in the realm of renin-angiotensin axis inhibition; the angiotensin II receptor antagonists in congestive heart failure.
    Martineau P; Goulet J
    Ann Pharmacother; 2001 Jan; 35(1):71-84. PubMed ID: 11197588
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A mechanistic interaction remains to be determined for elevated NTproBNP in heart failure patients receiving both an ACE inhibitor and aspirin.
    McLachlan CS; Zhang Z; Mossop P
    J Card Fail; 2007 Feb; 13(1):75-6. PubMed ID: 17339006
    [No Abstract]   [Full Text] [Related]  

  • 52. Quantifying the interaction between angiotensin-converting enzyme inhibitors and aspirin: are we using the right method?
    Etminan M
    Pharmacotherapy; 2001 Oct; 21(10):1247-9. PubMed ID: 11601671
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Angiotensin receptor blockers versus ACE inhibitors: prevention of death and myocardial infarction in high-risk populations.
    Epstein BJ; Gums JG
    Ann Pharmacother; 2005 Mar; 39(3):470-80. PubMed ID: 15701766
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials.
    Danchin N; Cucherat M; Thuillez C; Durand E; Kadri Z; Steg PG
    Arch Intern Med; 2006 Apr; 166(7):787-96. PubMed ID: 16606817
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aspirin-angiotensin-converting enzyme inhibitor coadministration and mortality in patients with heart failure: a dose-related adverse effect of aspirin.
    Guazzi M; Brambilla R; Reina G; Tumminello G; Guazzi MD
    Arch Intern Med; 2003 Jul; 163(13):1574-9. PubMed ID: 12860580
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interaction between cyclooxygenase and the renin-angiotensin-aldosterone system: rationale and clinical relevance.
    Meune C; Mourad JJ; Bergmann JF; Spaulding C
    J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):149-54. PubMed ID: 14608518
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
    Plosker GL; Sorkin EM
    Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Which interactions are there for equal doses of acetylsalicylic acid and ACE inhibitors?].
    Joost HG
    Dtsch Med Wochenschr; 2003 Feb; 128(8):398. PubMed ID: 12594628
    [No Abstract]   [Full Text] [Related]  

  • 59. Underutilization of ACE inhibitors in heart failure.
    Luzier AB; DiTusa L
    Pharmacotherapy; 1999 Nov; 19(11):1296-307. PubMed ID: 10555935
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aspirin inhibits the acute arterial and venous vasodilator response to captopril in patients with chronic heart failure.
    MacIntrye IM; Jhund PS; McMurray JJ
    Cardiovasc Drugs Ther; 2005 Aug; 19(4):261-5. PubMed ID: 16187007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.